Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. G. Kontopoulos
Atorvastatin and Micronized Fenofibrate Alone and in Combination in Type 2 Diabetes With Combined Hyperlipidemia
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Related publications
Incidence of Type 2 Diabetes in Familial Combined Hyperlipidemia
BMJ Open Diabetes Research and Care
Endocrinology
Metabolism
Diabetes
Canagliflozin: Efficacy and Safety in Combination With Metformin Alone or With Other Antihyperglycemic Agents in Type 2 Diabetes
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Effectiveness of Coelatura Aegyptiaca Extract Combination With Atorvastatin on Experimentally Induced Hyperlipidemia in Rats
Evidence-based Complementary and Alternative Medicine
Alternative Medicine
Complementary
Comparison of Teneligliptin and Atorvastatin on Lipid Profile in Patients With Type 2 Diabetes Mellitus
Current Research in Diabetes & Obesity Journal
SGLT2 Inhibitor Ipragliflozin Alone and Combined With Pioglitazone Prevents Progression of Nonalcoholic Steatohepatitis in a Type 2 Diabetes Rodent Model
Physiological Reports
Physiology
Treatment Options for Type 2 Diabetes in Adolescents and Youth: A Study of the Comparative Efficacy of Metformin Alone or in Combination With Rosiglitazone or Lifestyle Intervention in Adolescents With Type 2 Diabetes
Pediatric Diabetes
Internal Medicine
Pediatrics
Endocrinology
Perinatology
Child Health
Metabolism
Diabetes
Erratum To: Favourable Effects of Fenofibrate on Lipids and Cardiovascular Disease in Women With Type 2 Diabetes: Results From the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Effects of Fenofibrate in Patients With Type 2 Diabetes Mellitus Complicated by Diabetic Neuropathy
Diabetes Mellitus
Internal Medicine
Endocrinology
Metabolism
Diabetes
Paradoxical Decrease in HDL-cholesterol and Apolipoprotein A1 With Simvastatin and Atorvastatin in a Patient With Type 2 Diabetes
Annals of Clinical Biochemistry
Medicine
Clinical Biochemistry